Update in Pediatric Inflammatory Bowel Disease

Rheumatic Disease Clinics of North America

Volumn 39, Issue 4, 2013, Pages 789-799

  Rabizadeh, Shervin ^a   Dubinsky, Marla ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn disease; Inflammatory bowel disease; Pediatrics; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; FUNGUS ANTIBODY; IMMUNOMODULATING AGENT; INFLIXIMAB; INTERLEUKIN 10; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ACNE; ARTHRITIS; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIET THERAPY; DRUG CONTRAINDICATION; DRUG SAFETY; ENDOSCOPY; ENTERITIS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GROWTH DISORDER; HUMAN; IMMUNITY; LABORATORY TEST; MOON FACE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CROHN DISEASE; INFLAMMATORY BOWEL DISEASE; PEDIATRICS; ULCERATIVE COLITIS;

BONE DISEASES, METABOLIC; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS;

EID: 84886782875     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2013.03.010     Document Type: Review

References (59)

1. Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol 2008, 14:413-420.
2. Hildebrand H., Finkel Y., Grahnquist L., et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 2003, 52:1432-1434.
3. Perminow G., Brackmann S., Lyckander L.G., et al. Acharacterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009, 44:446-456.
4. Kugathasan S., Judd R.H., Hoffmann R.G., et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin:a statewide population-based study. JPediatr 2003, 143:525-531.
5. Baldassano R.N., Piccoli D.A. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999, 2:445-458.
6. Heyman M.B., Kirschner B.S., Gold B.D., et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. JPediatr 2005, 6:35-40.
7. Ahmad T., Satsangi J., McGovern D., et al. The genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001, 15:731-748.
8. Feeney M.A., Murphy F., Clegg A.J., et al. Acase-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002, 14:529-534.
9. Blanchard J.F., Bernstein C.N., Wajda A., et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001, 154:328-335.
10. Montgomery S.M., Wakefield A.J., Ekbom A. Sex-specific risks for pediatric onset among patients with Crohn's disease. Clin Gastroenterol Hepatol 2003, 1:303-309.
11. Corrao G., Tragnone A., Caprilli R., et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998, 27:397-404.
12. Robertson D.J., Sandler R.S. Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflamm Bowel Dis 2001, 7:51-57.
13. Laharie D., Debeugny S., Peeters M., et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001, 120:816-819.
14. Halfvarson J., Bodin L., Tysk C., et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003, 124:1767-1773.
15. Bonen D.K., Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology 2003, 124:521-536.
16. McCauley J.L., Abreu M.T. Genetics in diagnosing and managing inflammatory bowel disease. Gastroenterol Clin North Am 2012, 31:513-522.
17. Imielinski M., Baldassano R.N., Griffiths A., et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009, 41:1335-1340.
18. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458-466.
19. Glocker E.O., Kotlarz D., Boztug K., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. NEngl J Med 2009, 21:2033-2045.
20. Kanof M.E., Lake A.M., Bayless T.M. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988, 95:1523-1527.
21. Savage M.O., Beattie R.M., Camacho-Hubner C., et al. Growth in Crohn's disease. Acta Paediatr Suppl 1999, 88:89-92.
22. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002, 58(Suppl 1):7-10.
23. Ballinger A.B., Azooz O., El-Haj T., et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000, 46:694-700.
24. Hyams J.S., Moore R.E., Leichtner A.M., et al. Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease. JPediatr 1988, 112:893-898.
25. Passo M.H., Fitzgerald J.F., Brandt K.D. Arthritis associated with inflammatory bowel disease in children: relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci 1986, 31:492.
26. Rothfuss K.S., Stange E.F., Herrlinger K.R. Extraintestinal manifestations and complications in inflammatory bowel disease. World J Gastroenterol 2006, 12:4819.
27. Danese S., Semeraro S., Papa A., et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005, 11:7227.
28. Reveille J.D. Genetics of spondyloarthritis - beyond the MHC. Nat Rev Rheumatol 2012, 8:296-304.
29. Mack D.R., Lanton C., Markowitz J., et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007, 119:1113-1119.
30. Kostakis I.D., Cholidou K.G., Vaiopoulos A.G., et al. Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review. Dig Dis Sci 2013, 58:309-319.
31. Targan S.R. The utility of ANCA and ASCA in inflammatory bowel disease. Inflamm Bowel Dis 1999, 5:61-63. [discussion: 66-7].
32. Ruemmele F.M., Targan S.R., Levy G., et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998, 115:822-829.
33. Targan S.R., Landers C.J., Yang H., et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005, 128:2020-2028.
34. Dubinsky M.C., Ofman J.J., Urman M., et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001, 96:758-765.
35. Markowitz J., Kugathasan S., Dubinsky M.C., et al. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology. Inflamm Bowel Dis 2009, 15:714-719.
36. Dubinsky M.C., Kugathasan S., Mei L., et al. Increased immune reactivity predict aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 2008, 6:1105-1111.
37. Castellaneta S.P., Afzal N.A., Greenberg M., et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. JPediatr GastroenterolNutr 2004, 39:257-261.
38. Sharif F., McDermott M., Dillon M., et al. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol 2002, 97:1415-1420.
39. Fraquelli M., Colli A., Casazza G., et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005, 236:95-101.
40. Salbeni S., Rondonotti E., Iozzelli A., et al. Imaging of the small bowel in Crohn's disease: a review of old and new techniques. World J Gastroenterol 2007, 13:3279-3287.
41. Bodily K.D., Fletcher J.G., Solem C.A., et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography: correlation with endoscopic and histologic findings of inflammation. Radiology 2006, 238:505-516.
42. Lee S.S., Kim A.Y., Yang S.K., et al. Crohn's disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostictechniques. Radiology 2009, 251:751-761.
43. Borrelli O., Cordischi L., Cirulli M., et al. Polymeric dietalone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006, 4:744-753.
44. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007, (1). CD000542.
45. Markowitz J., Grancher K., Kohn N., et al. Amulticenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000, 119:895-902.
46. Hyams J., Crandall W., Kugathasan S., et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007, 132:863-873.
47. Turner D., Mack D., Leleiko N., et al. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology 2010, 138:2282-2291.
48. Dubinsky M.C., Mei L., Friedman M., et al. Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:1357-1366.
49. Sandborn W.J., Rutgeerts P.J., Reinisch W., et al. One year data from the Sonic Study: a randomized, double-blind trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. Gastroenterology 2009, 136:A-116.
50. Rosh J.R., Gross T., Mamula P., et al. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm Bowel Dis 2007, 13:1024-1030.
51. Cucciara S., Escher J.C., Hildebrand H. Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies. JPediatr Gastroenterol Nutr 2009, 48:257-267.
52. Sentongo T.A., Semaeo E.J., Stettler N., et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002, 76:1077-1081.
53. Van Staa T.P., Cooper C., Brusse L.S., et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003, 125:1591-1597.
54. Sylvester F.A. IBD and skeletal health: children are not small adults!. Inflamm Bowel Dis 2005, 11:1020-1023.
55. Bachrach L.K. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am 2005, 34:521-535.
56. Mackner L., Crandall W., Szigethy E. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006, 12(3):239-244.
57. Mawdsley J.E., Rampton D.S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005, 54:1481-1491.
58. Deter H.C., Keller W., von Wietersheim J., et al. Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis 2007, 13:745-752.
59. Sands B.E., Cuffari C., Katz J., et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004, 10:677-692.